Keywords:
Bibliometric Analysis, HPV, Cervical Cancer, Children

  • Abstract

    This study aimed to examine trends in research on HPV and Cervical Cancer in Children from 2013 to 2023. This study uses a qualitative research methodology with a bibliometric analysis approach. The primary data of this research were collected through the Scopus database by identifying articles/journals using the keywords TITLE-ABS-KEY ("HPV" AND "Cervical Cancer") AND "Children" PUBYEAR > 2013 AND PUBYEAR < 2023 AND (LIMIT- TO (OA)) AND (LIMIT-TO (SUBJAREA "Medicine")) AND (LIMIT-TO (LANGUAGE, "ENGLISH")). The result of this study is the United States became the first country to produce many articles from 2013 to 2023. Furthermore, Medicine and Biochemistry, Genetics, and Molecular Biology are the highest sources of publication. Topics related to cervical cancer, human papillomavirus, and vaccination have the network's most frequent occurrences and the highest total link strength. In addition, topics such as cervical cancer, immunization, HPV, and HPV vaccines have a big opportunity for future research. This study successfully explained the importance of vaccination in children to strengthen immunity to HPV and Cervical Cancer in the future. However, this study has limitations in terms of data sources, because the Scopus database has closed access.

  • References

    1. Roblin DW, Ritzwoller DP, Rees DI, Carroll NM, Chang A, Daley MF. The influence of deductible health plans on receipt of the human papillomavirus vaccine series. J Adolesc Heal 2014;54:275–81. https://doi.org/10.1016/j.jadohealth.2013.12.001.
    2. Sohn AH, Chalermchockcharoenkit A, Teeraananchai S, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, et al. Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections among Asian Young Adult Women with Perinatally Acquired HIV Compared with HIV-Negative Peers. Sex Transm Dis 2021;48:200–5. https://doi.org/10.1097/OLQ.0000000000001294.
    3. Malehere J, Armini NKA, Ulfiana E, Dewi KI. Behaviour of cervical cancer prevention among fertile age woman: health promotion approach. Int J Public Heal Sci 2022;11:793–9. https://doi.org/10.11591/ijphs.v11i3.21329.
    4. Karcheva M, Yordanov A, Kostadinov S. An overview of cervical cancer epidemiology and prevention in Bulgaria. GERMS 2020;10:322–7. https://doi.org/10.18683/germs.2020.1224.
    5. Rahmawati NA, Kurniawati EM, Wibowo A, Indriani D. FACTORS INFLUENCING WOMEN WITH DISABILITY TO ACCESS BREAST AND CERVICAL CANCER SCREENING: A SCOPING REVIEW. Southeast Asian J Trop Med Public Health 2022;53:135–54.
    6. Vos RA, Pasmans H, Tymchenko L, Janga-Jansen AVA, Baboe-Kalpoe S, Hulshof K, et al. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands. Vaccine 2020;38:2816–26. https://doi.org/10.1016/j.vaccine.2020.02.017.
    7. Ukumo EY, Weldehawariat FG, Dessalegn SA, Minamo DM, Weldehawaryat HN. Acceptance of Human Papillomavirus Vaccination and Associated Factors among Girls in Arba Minch Town, Southern Ethiopia, 2020. Infect Dis Obstet Gynecol 2022;2022. https://doi.org/10.1155/2022/7303801.
    8. Flores YN, Salmerón J, Glenn BA, Lang CM, Chang LC, Bastani R. Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study. Int J Public Health 2019;64:323–32. https://doi.org/10.1007/s00038-018-1176-5.
    9. Portnoy A, Abbas K, Sweet S, Kim JJ, Jit M. Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: A comparative modelling study. BMJ Glob Heal 2021;6. https://doi.org/10.1136/bmjgh-2021-006940.
    10. Biederman E, Donahue K, Sturm L, Champion V, Zimet G. The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children. Hum Vaccines Immunother 2021;17:1000–5. https://doi.org/10.1080/21645515.2020.1817714.
    11. Jit M, Brisson M. Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9–14-year-old girls against human papillomavirus. Int J Cancer 2018;143:317–23. https://doi.org/10.1002/ijc.31321.
    12. Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, et al. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. Prev Med (Baltim) 2018;114:149–55. https://doi.org/10.1016/j.ypmed.2018.06.017.
    13. Berkowitz Z, Malone M, Rodriguez J, Saraiya M. Providers’ beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012. Prev Med (Baltim) 2015;81:405–11. https://doi.org/10.1016/j.ypmed.2015.10.007.
    14. Tay SK, Hsu T-Y, Pavelyev A, Walia A, Kulkarni AS. Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis. BJOG An Int J Obstet Gynaecol 2018;125:478–86. https://doi.org/10.1111/1471-0528.15106.
    15. Sun X, Lei H, Xie X, Ruan G, An J, Sun P. Risk factors for residual disease in hysterectomy specimens after conization in post-menopausal patients with cervical intraepithelial neoplasia grade 3. Int J Gen Med 2020;13:1067–74. https://doi.org/10.2147/IJGM.S280576.
    16. Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine 2018;36:4761–7. https://doi.org/10.1016/j.vaccine.2018.02.003.
    17. Tchounga B, Horo A, Boni S, Tanon A, Folquet MA, Garrigue I, et al. Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d’Ivoire. Sex Transm Infect 2021;97:238–43. https://doi.org/10.1136/sextrans-2019-054420.
    18. Hu Y, Zhang X, He Y, Ma Z, Xie Y, Lu X, et al. Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study. Asia Pac J Clin Oncol 2020;16:392–9. https://doi.org/10.1111/ajco.13398.
    19. Kim Y-T, Serrano B, Lee J-K, Lee H, Lee S-W, Freeman C, et al. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea. Papillomavirus Res 2019;7:26–42. https://doi.org/10.1016/j.pvr.2018.12.002.
    20. Yagi A, Ueda Y, Tanaka Y, Nakae R, Kakubari R, Morimoto A, et al. Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation. Hum Vaccines Immunother 2018;14:2497–502. https://doi.org/10.1080/21645515.2018.1480240.
    21. Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health 2017;18. https://doi.org/10.1186/s12889-017-4567-2.
    22. Jacot-Guillarmod M, Pasquier J, Greub G, Bongiovanni M, Achtari C, Sahli R. Impact of HPV vaccination with Gardasil® in Switzerland. BMC Infect Dis 2017;17. https://doi.org/10.1186/s12879-017-2867-x.
    23. Chávez-lópez MG, Zúñiga-garcía V, Castro-magdonel BE, Vera E, Garrido E, Sánchez-ramos J, et al. Eag1 gene and protein expression in human retinoblastoma tumors and its regulation by pRb in HeLa cells. Genes (Basel) 2020;11. https://doi.org/10.3390/genes11020119.
    24. Balla BC, Terebessy A, Tóth E, Balázs P. Hungarian high school students’ attitudes toward HPV vaccination. New Med 2015;19:94–9. https://doi.org/10.5604/14270994.1179850.
    25. Yi B, Xu Q, Zhang Z, Zhang J, Xu Y, Huang L, et al. Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions. Front Oncol 2022;12. https://doi.org/10.3389/fonc.2022.812076.
    26. Joura EA, Kyrgiou M, Bosch FX, Kesic V, Niemenen P, Redman CW, et al. Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy. Eur J Cancer 2019;116:21–6. https://doi.org/10.1016/j.ejca.2019.04.032.
    27. Ganczak M, Owsianka B, Korzeń M. Factors that predict parentalwillingness to have their children vaccinated against HPV in a country with low HPV vaccination coverage. Int J Environ Res Public Health 2018;15. https://doi.org/10.3390/ijerph15040645.
    28. Burger EA, Smith MA, Killen J, Sy S, Simms KT, Canfell K, et al. Projected time to elimination of cervical cancer in the USA: a comparative modelling study. Lancet Public Heal 2020;5:e213–22. https://doi.org/10.1016/S2468-2667(20)30006-2.
    29. Min K-J, Kwon S-H, Kim S, Kim HJ, Seong SJ, Song YJ, et al. Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline. J Gynecol Oncol 2016;27. https://doi.org/10.3802/jgo.2016.27.e30.
    30. Degarege A, Krupp K, Fennie K, Li T, Stephens DP, Marlow LA V, et al. Urban-Rural Inequities in the Parental Attitudes and Beliefs Towards Human Papillomavirus Infection, Cervical Cancer, and Human Papillomavirus Vaccine in Mysore, India. J Pediatr Adolesc Gynecol 2018;31:494–502. https://doi.org/10.1016/j.jpag.2018.03.008.
    31. Ghebrendrias S, Pfeil S, Crouthamel B, Chalmiers M, Kully G, Mody S. An Examination of Misconceptions and Their Impact on Cervical Cancer Prevention Practices among Sub-Saharan African and Middle Eastern Refugees. Heal Equity 2021;5:382–9. https://doi.org/10.1089/heq.2020.0125.
    32. Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation. Vaccine 2022;40:A2–9. https://doi.org/10.1016/j.vaccine.2021.04.025.
    33. Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, et al. Realistic fear of cervical cancer risk in Japan depending on birth year. Hum Vaccines Immunother 2017;13:1700–4. https://doi.org/10.1080/21645515.2017.1292190.
    34. Fisher-Borne M, Preiss AJ, Black M, Roberts K, Saslow D. Early Outcomes of a Multilevel Human Papillomavirus Vaccination Pilot Intervention in Federally Qualified Health Centers. Acad Pediatr 2018;18:S79–84. https://doi.org/10.1016/j.acap.2017.11.001.
    35. Simoens S, Bento-Abreu A, Merckx B, Joubert S, Vermeersch S, Pavelyev A, et al. Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium. Front Pharmacol 2021;12. https://doi.org/10.3389/fphar.2021.628434.
    36. Yang S, Bai L, Xu W, Zhang R, Hu D, Nie Y, et al. Profiling the real-world management status of high-risk human papillomavirus infection: a protocol to establish a prospective cohort of high-risk human papillomavirus-infected women in Lueyang County, China. BMJ Open 2022;12. https://doi.org/10.1136/bmjopen-2022-062678.
    37. Gallagher KE, Erio T, Baisley K, Lees S, Watson-Jones D. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: A controlled before and after study. BMC Health Serv Res 2018;18. https://doi.org/10.1186/s12913-018-2976-2.
    38. Enujioke SC, Shedd-Steele R, Daggy J, Burney HN, Head KJ, Kasting ML, et al. County-level correlates of completed HPV vaccination in Indiana. Vaccine 2023;41:5752–7. https://doi.org/10.1016/j.vaccine.2023.07.044.
    39. Appiah EO, Oti-Boadi E, Appiah S, Bakkari MA, Menka MA, Awuah DB, et al. Acceptance of HPV vaccination in boys among mothers from selected churches in Accra, Ghana. BMC Public Health 2023;23. https://doi.org/10.1186/s12889-023-16028-5.
    40. Laugesen MJ, Mistry R, Carameli KA, Ribisl KM, Needleman J, Bastani R. Early policy responses to the human papillomavirus vaccine in the united states, 2006-2010. J Adolesc Heal 2014;55:659–64. https://doi.org/10.1016/j.jadohealth.2014.04.015.
    41. Sasaki S, Metoki H, Satoh M, Murakami T, Tanoue K, Tanaka K, et al. Association of subjective health and abnormal cervical cytology in Japanese pregnant women: An adjunct study of the Japan Environment and Children’s Study. Prev Med Reports 2021;24. https://doi.org/10.1016/j.pmedr.2021.101525.
    42. Östensson E, Alder S, Elfström KM, Sundström K, Zethraeus N, Arbyn M, et al. Barriers to and facilitators of compliance with clinic-based cervical cancer screening: Population-based cohort study of women aged 23-60 years. PLoS One 2015;10. https://doi.org/10.1371/journal.pone.0128270.
    43. Nascimento MDSB, Vidal FCB, Silva MACN, Batista JE, Lacerda Barbosa MC, Muniz Filho WE, et al. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil. BMC Womens Health 2018;18. https://doi.org/10.1186/s12905-017-0499-3.
    44. Addisu D, Gebeyehu NA, Belachew YY. Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis. BMC Womens Health 2023;23. https://doi.org/10.1186/s12905-023-02412-1.
    45. Beer H, Hibbitts S, Brophy S, Rahman MA, Waller J, Paranjothy S. Does the HPV vaccination programme have implications for cervical screening programmes in the UK? Vaccine 2014;32:1828–33. https://doi.org/10.1016/j.vaccine.2014.01.087.
    46. Shafer LA, Jeffrey I, Elias B, Shearer B, Canfell K, Kliewer E. Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model. Vaccine 2013;31:4848–55. https://doi.org/10.1016/j.vaccine.2013.07.073.
    47. Mabeya H, Menon S, Weyers S, Naanyu V, Mwaliko E, Kirop E, et al. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting. BMC Cancer 2018;18. https://doi.org/10.1186/s12885-018-4382-x.
    48. Zeng Y, Moscicki A-B, Sahasrabuddhe V V, Garcia F, Woo H, Hsu C-H, et al. A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - Clinical protocol. BMC Cancer 2019;19. https://doi.org/10.1186/s12885-019-5444-4.
    49. Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: A systematic review and meta-analysis. Int J Epidemiol 2013;42:896–908. https://doi.org/10.1093/ije/dyt049.
    50. Alonso S, Cambaco O, Maússe Y, Matsinhe G, Macete E, Menéndez C, et al. Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique. BMC Public Health 2019;19. https://doi.org/10.1186/s12889-019-7338-4.
    51. Carmo RD, Jerónimo C, Pereira L, Dias Á, Patricio V. State of the Art of Business Models: A Bibliometric Analysis. Sustain 2023;15. https://doi.org/10.3390/su15054482.
    52. Figueiredo D, Sanghavi P. Bibliometric Analysis of Published Literature Utilizing Optogenetics as a Technique in Neuroscience: 2010–2020. J Scientometr Res 2023;12:144–75. https://doi.org/10.5530/jscires.12.1.001.
    53. Abejón R. An Overview to Technical Solutions for Molybdenum Removal: Perspective from the Analysis of the Scientific Literature on Molybdenum and Drinking Water (1990–2019). Water (Switzerland) 2022;14. https://doi.org/10.3390/w14132108.
    54. Salam S, Senin AA. A Bibliometric Study on Innovative Behavior Literature (1961–2019). SAGE Open 2022;12. https://doi.org/10.1177/21582440221109589.
    55. Liao H, Li X. Status and Trends of Research on China’s Third Front Construction in English Language and Brief Comparison With Chinese Counterpart. SAGE Open 2023;13. https://doi.org/10.1177/21582440231157614.
    56. Kristia K, Kovács S, Bács Z, Rabbi MF. A Bibliometric Analysis of Sustainable Food Consumption: Historical Evolution, Dominant Topics and Trends. Sustain 2023;15. https://doi.org/10.3390/su15118998.
    57. Reyes Ayala L, Medina-Quintero JM, Morales Sáenz FI, Ortiz Rodríguez F. Venture capital: Analysis of its evolution and emerging research trends. Rev Venez Gerenc 2022;27:1044–57. https://doi.org/10.52080/RVGLUZ.27.99.12.
    58. Liu L, Cui H, Nie Y. Cite Space-Based Bibliometric Analysis of Green Marketing. Sustain 2023;15. https://doi.org/10.3390/su15129840.
    59. Aktaş İ, Karamustafaoğlu O. Evaluation of the Published Articles in Education Field: A Bibliometric Analysis. Hacettepe Egit Derg 2022;37:1037–50. https://doi.org/10.16986/HUJE.2021067584.
    60. Stadnyk S, Okun D, Bondar A, Sereda N. Sports branding as an object of scientific analysis based on the study of publications in the international scientometric database Scopus. Slobozhanskyi Her Sci Sport 2023;27:81–91. https://doi.org/10.15391/snsv.2023-2.004.
    61. Duan C. A State-of-the-Art Review of Sharing Economy Business Models and a Forecast of Future Research Directions for Sustainable Development: A Bibliometric Analysis Approach. Sustain 2023;15. https://doi.org/10.3390/su15054568.
    62. Chansanam W, Poonpon K, Jaroenruen Y, Kaewboonma N. Global Research Trend of Korean Popular Music: A Bibliometric Analysis. J Scientometr Res 2022;11:419–26. https://doi.org/10.5530/jscires.11.3.48.
    63. Miranda AC, Fidélis T, Roebeling P, Meireles I. Assessing the Inclusion of Water Circularity Principles in Environment-Related City Concepts Using a Bibliometric Analysis. Water (Switzerland) 2022;14. https://doi.org/10.3390/w14111703.
    64. Tosun C. Bibliometric Analysis of Educational Research in Turkey: 1981-2020 WoS Articles*. Hacettepe Egit Derg 2022;37:942–56. https://doi.org/10.16986/HUJE.2022.451.
    65. Sun Y, Lan G. A bibliometric analysis on L2 writing in the first 20 years of the 21st century: Research impacts and research trends. J Second Lang Writ 2023;59. https://doi.org/10.1016/j.jslw.2023.100963.
    66. Miah MB, Haque MS, Khaleque MA, Santos RM. Sludge Management in the Textile Industries of Bangladesh: An Industrial Survey of the Impact of the 2015 Standards and Guidelines. Water (Switzerland) 2023;15. https://doi.org/10.3390/w15101901.
    67. Muhammad UA, Fuad M, Ariyani F, Suyanto E. Bibliometric analysis of local wisdom-based learning: Direction for future history education research. Int J Eval Res Educ 2022;11:2209–22. https://doi.org/10.11591/ijere.v11i4.23547.
    68. Liu W, Huangfu X, Wang H. Citation advantage of COVID-19-related publications. J Inf Sci 2023. https://doi.org/10.1177/01655515231174385.
    69. Li C, Bai L, Yao L, Waller ST, Liu W. A bibliometric analysis and review on reinforcement learning for transportation applications. Transp B 2023;11. https://doi.org/10.1080/21680566.2023.2179461.
    70. Dragović B, Zrnić N, Tzannatos E, Kosanić N, Dragović A. A bibliometric analysis and assessment of container terminal operations research. Marit Bus Rev 2023. https://doi.org/10.1108/MABR-07-2022-0035.
    71. Hou X, Li R, Song Z. A Bibliometric Analysis of Wicked Problems: From Single Discipline to Transdisciplinarity. Fudan J Humanit Soc Sci 2022;15:299–329. https://doi.org/10.1007/s40647-022-00346-w.
    72. Halepoto H, Gong T, Memon H. A Bibliometric Analysis of Antibacterial Textiles. Sustain 2022;14. https://doi.org/10.3390/su141811424.
    73. Sajovic I, Boh Podgornik B. Bibliometric Analysis of Visualizations in Computer Graphics: A Study. SAGE Open 2022;12. https://doi.org/10.1177/21582440211071105.
    74. Zakaria H, Kamarudin D, Fauzi MA, Wider W. Mapping the helix model of innovation influence on education: A bibliometric review. Front Educ 2023;8. https://doi.org/10.3389/feduc.2023.1142502.
    75. Phoong SW, Phoong SY, Khek SL. Systematic Literature Review With Bibliometric Analysis on Markov Switching Model: Methods and Applications. SAGE Open 2022;12. https://doi.org/10.1177/21582440221093062.
    76. Yu Z, Li M. A bibliometric analysis of Community of Inquiry in online learning contexts over twenty-five years. Educ Inf Technol 2022;27:11669–88. https://doi.org/10.1007/s10639-022-11081-w.
    77. Büyükkidik S. A Bibliometric Analysis: A Tutorial for the Bibliometrix Package in R Using IRT Literature. J Meas Eval Educ Psychol 2022;13:164–93. https://doi.org/10.21031/EPOD.1069307.
    78. Bashar A, Nyagadza B, Ligaraba N, Maziriri ET. The influence of Covid-19 on consumer behaviour: a bibliometric review analysis and text mining. Arab Gulf J Sci Res 2023. https://doi.org/10.1108/AGJSR-12-2022-0281.
    79. Alsmadi AA, Al-Okaily M, Alrawashdeh N, Al-Gasaymeh A, Moh’d Al-hazimeh A, Zakari A. A Bibliometric Analysis of Green Bonds and Sustainable Green Energy: Evidence from the Last Fifteen Years (2007–2022). Sustain 2023;15. https://doi.org/10.3390/su15075778.
    80. Luttjeboer J, Wondimu A, Van der Schans J, Postma MJ. Maximising the potential of HPV vaccines. Lancet Glob Heal 2020;8:e460–1. https://doi.org/10.1016/S2214-109X(20)30073-5.
    81. Lechuga J, Prieto C, Mata H, Belknap RA, Varela I. Culture and sexuality-related communication as sociocultural precursors of HPV vaccination among mother-daughter dyads of Mexican descent. Prev Med Reports 2020;19. https://doi.org/10.1016/j.pmedr.2020.101105.
    82. Yi JK, Lackey SC, Zahn MP, Castaneda J, Hwang JP. Human papillomavirus knowledge and awareness among vietnamese mothers. J Community Health 2013;38:1003–9. https://doi.org/10.1007/s10900-013-9709-6.
    83. Knight G, Roberts B. Awareness of oral and genital human papillomavirus (HPV) infection in young adolescents prior to gender-neutral vaccination. BMJ Sex Reprod Heal 2021;47:110–6. https://doi.org/10.1136/bmjsrh-2019-200410.
    84. Moss JL, McCarthy SH, Gilkey MB, Brewer NT. Application of the carolina framework for cervical cancer prevention. Gynecol Oncol 2014;132:S33–40. https://doi.org/10.1016/j.ygyno.2013.12.004.
    85. Chodick G, Leader AE, Larson S. Catch-up HPV vaccination and subsequent uptake of papanicolaou testing in a state-mandated health system. Cancer Prev Res 2021;14:415–9. https://doi.org/10.1158/1940-6207.CAPR-20-0570.
    86. Cosmas NT, Nimzing L, Egah D, Famooto A, Adebamowo SN, Adebamowo CA. Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria. BMC Infect Dis 2022;22. https://doi.org/10.1186/s12879-022-07215-7.
    87. Mahomed K, Evans D, Sauls C, Richter K, Smith J, Firnhaber C. Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa. Pan Afr Med J 2014;17:189. https://doi.org/10.11604/pamj.2014.17.189.3454.
    88. Tay SK, Lee B-W, Sohn WY, Lee I-H, Mathur G, Sanicas M, et al. Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore. Singapore Med J 2018;59:370–82. https://doi.org/10.11622/smedj.2017085.
    89. Gichane MW, Calo WA, McCarthy SH, Walmer KA, Boggan JC, Brewer NT. Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program. J Pediatr Adolesc Gynecol 2017;30:96–101. https://doi.org/10.1016/j.jpag.2016.07.003.
    90. Lukács A, Máté Z, Farkas N, Mikó A, Tenk J, Hegyi P, et al. The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis. BMC Public Health 2020;20. https://doi.org/10.1186/s12889-020-08753-y.
    91. Rao DW, Bayer CJ, Liu G, Chikandiwa A, Sharma M, Hathaway CL, et al. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa. J Int AIDS Soc 2022;25. https://doi.org/10.1002/jia2.26021.
    92. Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, et al. HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia. Infect Agent Cancer 2018;13. https://doi.org/10.1186/s13027-018-0201-x.
    93. Héquet D, Pouget N, Estevez J-P, Robain M, Rouzier R. Age impact on human papillomavirus vaccination in France in 2014: A study from the National Health Insurance Database. Bull Cancer 2015;102:892–7. https://doi.org/10.1016/j.bulcan.2015.09.005.
    94. Zhao R, Prizment A, Kulasingam S. Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011–2018. Cancer Causes Control 2023;34:543–52. https://doi.org/10.1007/s10552-023-01685-z.
    95. Oketch SY, Ochomo EO, Orwa JA, Mayieka LM, Abdullahi LH. Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: A systematic review and meta-analysis. BMJ Open 2023;13. https://doi.org/10.1136/bmjopen-2022-067164.
    96. Viviano M, Kenfack B, Catarino R, Tincho E, Temogne L, Benski A-C, et al. Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa. BMC Womens Health 2017;17. https://doi.org/10.1186/s12905-016-0355-x.
    97. Getrich CM, Broidy LM, Kleymann E, Helitzer DL, Kong AS, Sussman AL. Different models of HPV vaccine decision-making among adolescent girls, parents, and health-care clinicians in New Mexico. Ethn Heal 2014;19:47–63. https://doi.org/10.1080/13557858.2013.857767.
    98. Creed S, Walsh E, Foley T. A qualitative study of parental views of HPV vaccination in Ireland. Eur J Gen Pract 2021;27:1–9. https://doi.org/10.1080/13814788.2020.1851677.
    99. Chang IJ, Huang R, He W, Zhang S-K, Wang S-M, Zhao F-H, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: A cross-sectional study. BMC Public Health 2013;13. https://doi.org/10.1186/1471-2458-13-916.
    100. Song B, Ding C, Chen W, Sun H, Zhang M, Chen W. Incidence and mortality of cervical cancer in China, 2013. Chinese J Cancer Res 2017;29:471–6. https://doi.org/10.21147/j.issn.1000-9604.2017.06.01.
    101. Sharma M, Kapoor CS. Knowledge and awareness regarding HPV infection and PAP smear screening in reproductive aged females of rural India. Clin Epidemiol Glob Heal 2020;8:628–31. https://doi.org/10.1016/j.cegh.2019.12.016.
    102. Morales-Campos DY, Snipes SA, Villarreal EK, Crocker LC, Guerrero A, Fernandez ME. Cervical cancer, human papillomavirus (HPV), and HPV vaccination: exploring gendered perspectives, knowledge, attitudes, and cultural taboos among Mexican American adults. Ethn Heal 2021;26:206–24. https://doi.org/10.1080/13557858.2018.1494821.
    103. Moraga-Llop FA. Ten years of human papillomavirus vaccination. From dermatology to oncology via infectology. An Pediatr 2018;88:289.e1-289.e6. https://doi.org/10.1016/j.anpedi.2017.12.013.
    104. Shimizu Y, Hirai K, Ueda Y, Yagi A, Ohtake F. Impact of the Threat of COVID-19 Infections on the Perceived Risk to HPV Vaccination. Vaccines 2022;10. https://doi.org/10.3390/vaccines10050829.
    105. Cordoba-Sanchez V, Tovar-Aguirre OL, Franco S, Arias Ortiz NE, Louie K, Sanchez GI, et al. Perception about barriers and facilitators of the school-based HPV vaccine program of Manizales, Colombia: A qualitative study in school-enrolled girls and their parents. Prev Med Reports 2019;16. https://doi.org/10.1016/j.pmedr.2019.100977.
    106. Kim HW. Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: Quasi experimental study. BMC Int Health Hum Rights 2015;15. https://doi.org/10.1186/s12914-015-0042-2.
    107. Wang Y-Y, Li L, Wei S, Peng J, Yuan S-X, Xie J-S, et al. Human papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen City, South China. Asian Pacific J Cancer Prev 2013;14:7483–7. https://doi.org/10.7314/APJCP.2013.14.12.7483.
    108. Yaghoubi M, Nojomi M, Vaezi A, Erfani V, Mahmoudi S, Ezoji K, et al. Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran. Value Heal Reg Issues 2018;15:112–9. https://doi.org/10.1016/j.vhri.2018.03.001.
    109. Gari A, Ghazzawi MA, Ghazzawi SA, Alharthi SM, Yanksar EA, Almontashri RM, et al. Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia. Vaccine X 2023;15. https://doi.org/10.1016/j.jvacx.2023.100361.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to cite

Nadhiroh, A., & Verma, E. I. (2025). A Bibliometric Analysis: Strengthening Immunity of Children to Prevent HPV and Cervical Cancer. Multidisciplinary Reviews, (| Accepted Articles). Retrieved from https://malque.pub/ojs/index.php/mr/article/view/8133
  • Article viewed - 101